Data / Form D filings / Celularity Inc
Celularity Inc: Form D filings
Celularity Inc, a biotechnology company in Florham Park, NJ, filed 5 Form D notices with the SEC between 2022 and 2025. The latest, on November 3, 2025, reports $2 million sold of a $6.7 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 170 PARK AVENUE, Florham Park, NJ, 07932
- Phone
- (908) 768-2170
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1752828
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | New notice | $6,666,667 | $2,000,000 | $4,666,667 | 1 | Oct 24, 2025 | sec.gov |
| Aug 5, 2025 | New notice | $6,812,230 | $6,812,230 | 1 | Jul 21, 2025 | sec.gov | |
| Aug 5, 2025 | New notice | $2,000,000 | $2,000,000 | 1 | Jul 30, 2025 | sec.gov | |
| Aug 5, 2025 | New notice | $1,035,000 | $1,035,000 | 14 | Jul 22, 2025 | sec.gov | |
| May 27, 2022 | New notice | $30,000,007 | $30,000,007 | 1 | May 20, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Diane A. Parks | Director | |
| Peter A. Diamandis | Director | |
| John R. Haines | Executive Officer | |
| Vincent A. LeVien | Director | |
| Joseph R. DosSantos | Executive Officer | |
| Robert J. Hariri | Executive Officer, Director | |
| Geoffrey A. Ling | Director | |
| Stephen A. Brigido | Executive Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Nov 3, 2025 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celularity Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.